Ghost Tree Capital’s TherapeuticsMD TXMD Stock Holding History

Ghost Tree Capital’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,000	Closed	-$1.7M	–	97
2016 Q3	$1.7M	Buy	+5,000	New	+$1.83M	0.28%	72
2015 Q3	–	Sell	-8,000	Closed	-$2.84M	–	91
2015 Q2	$3.14M	Sell	8,000 -4,000	-33%	-$1.41M	1.02%	45
2015 Q1	$3.63M	Sell	12,000 -736	-6%	-$180K	1.31%	36
2014 Q4	$2.83M	Sell	12,736 -2,264	-15%	-$467K	1.36%	35
2014 Q3	$3.48M	Buy	15,000 +10,000	+200%	+$2.52M	1.89%	23
2014 Q2	$1.1M	Buy	5,000 +1,000	+25%	+$223K	0.78%	40
2014 Q1	$1.26M	Buy	+4,000	New	+$1.27M	0.75%	45

Other funds holding TXMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ghost Tree Capital's TXMD Position: Q4 2016 in Review

Ghost Tree Capital sold out of TherapeuticsMD (TXMD) in Q4 2016, closing a stake of 5,000 shares — an estimated $1.7M sold.

Ghost Tree Capital first reported a position in TXMD in Q1 2014 and held it in 7 quarters. The position peaked at $3.63M in Q1 2015. 146 funds tracked by Wall St. Rank hold TXMD as of Q4 2016.

Ghost Tree Capital reported no remaining TherapeuticsMD position as of Q4 2016 after selling out during the quarter.
Ghost Tree Capital sold 5,000 TherapeuticsMD shares in Q4 2016, an estimated $1.7M.
Ghost Tree Capital first reported a position in TherapeuticsMD in Q1 2014 and held it in 7 quarters.
Ghost Tree Capital's TherapeuticsMD position peaked at $3.63M in Q1 2015.
146 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2016.

Based on Ghost Tree Capital's 13F filing for Q4 2016, filed 14 Feb 2017.